Cardioprotective and antiarrhythmic effects of resveratrol--a modern perspective on an old treatment: editorial to "resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction" by Chen et al.
Liew
Reginald
R
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D002316:Cardiotonic Agents / Q000494:pharmacology*; D004358:Drug Therapy / Q000379:methods* / Q000639:trends*; D006801:Humans; D009203:Myocardial Infarction / Q000503:physiopathology / Q000517:prevention & control*; D051381:Rats; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology* / Q000627:therapeutic use; D015996:Survival Rate / Q000639:trends*; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000503:physiopathology / Q000517:prevention & control*; D054141:Ventricular Flutter / Q000503:physiopathology / Q000517:prevention & control*
D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D013267:Stilbenes; D000077185:Resveratrol